Literature DB >> 31005274

SON haploinsufficiency causes impaired pre-mRNA splicing of CAKUT genes and heterogeneous renal phenotypes.

Jung-Hyun Kim1, Eun Young Park1, David Chitayat2, David L Stachura3, Jörg Schaper4, Kristin Lindstrom5, Tamison Jewett6, Dagmar Wieczorek7, Jos M Draaisma8, Margje Sinnema9, Christianne Hoeberigs10, Maja Hempel11, Kristine K Bachman12, Andrea H Seeley12, Joshua K Stone1, Hyun Kyung Kong1, Lana Vukadin1, Alexander Richard1, Deepali N Shinde13, Kirsty McWalter14, Yue Cindy Si14, Ganka Douglas14, Ssang-Taek Lim15, Lisenka E L M Vissers16, Mathieu Lemaire17, Eun-Young Erin Ahn18.   

Abstract

Although genetic testing is increasingly used in clinical nephrology, a large number of patients with congenital abnormalities of the kidney and urinary tract (CAKUT) remain undiagnosed with current gene panels. Therefore, careful curation of novel genetic findings is key to improving diagnostic yields. We recently described a novel intellectual disability syndrome caused by de novo heterozygous loss-of-function mutations in the gene encoding the splicing factor SON. Here, we show that many of these patients, including two previously unreported, exhibit a wide array of kidney abnormalities. Detailed phenotyping of 14 patients with SON haploinsufficiency identified kidney anomalies in 8 patients, including horseshoe kidney, unilateral renal hypoplasia, and renal cysts. Recurrent urinary tract infections, electrolyte disturbances, and hypertension were also observed in some patients. SON knockdown in kidney cell lines leads to abnormal pre-mRNA splicing, resulting in decreased expression of several established CAKUT genes. Furthermore, these molecular events were observed in patient-derived cells with SON haploinsufficiency. Taken together, our data suggest that the wide spectrum of phenotypes in patients with a pathogenic SON mutation is a consequence of impaired pre-mRNA splicing of several CAKUT genes. We propose that genetic testing panels designed to diagnose children with a kidney phenotype should include the SON gene.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SON haploinsufficiency; gene expression; genetic mutations; pediatric nephrology; pre-mRNA splicing

Year:  2019        PMID: 31005274      PMCID: PMC6534475          DOI: 10.1016/j.kint.2019.01.025

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  35 in total

Review 1.  The zebrafish pronephros: a genetic system for studies of kidney development.

Authors:  I A Drummond
Journal:  Pediatr Nephrol       Date:  2000-05       Impact factor: 3.714

Review 2.  Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.

Authors:  G Wu; S Somlo
Journal:  Mol Genet Metab       Date:  2000-01       Impact factor: 4.797

3.  Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study.

Authors:  Stefanie Weber; Vincent Moriniere; Tanja Knüppel; Marina Charbit; Jirí Dusek; Gian Marco Ghiggeri; Augustina Jankauskiené; Sevgi Mir; Giovanni Montini; Amira Peco-Antic; Elke Wühl; Aleksandra M Zurowska; Otto Mehls; Corinne Antignac; Franz Schaefer; Remi Salomon
Journal:  J Am Soc Nephrol       Date:  2006-09-13       Impact factor: 10.121

Review 4.  The cellular basis of kidney development.

Authors:  Gregory R Dressler
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

5.  Polycystin-2 expression is developmentally regulated.

Authors:  G S Markowitz; Y Cai; L Li; G Wu; L C Ward; S Somlo; V D D'Agati
Journal:  Am J Physiol       Date:  1999-07

6.  Cadherin-17 is required to maintain pronephric duct integrity during zebrafish development.

Authors:  Julia Horsfield; Anassuya Ramachandran; Katja Reuter; Edward LaVallie; Lisa Collins-Racie; Kathryn Crosier; Philip Crosier
Journal:  Mech Dev       Date:  2002-07       Impact factor: 1.882

7.  Overexpression of PKD1 causes polycystic kidney disease.

Authors:  Caroline Thivierge; Almira Kurbegovic; Martin Couillard; Richard Guillaume; Olivier Coté; Marie Trudel
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

Review 8.  Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).

Authors:  Catherine Boucher; Richard Sandford
Journal:  Eur J Hum Genet       Date:  2004-05       Impact factor: 4.246

Review 9.  Polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

10.  ESEfinder: A web resource to identify exonic splicing enhancers.

Authors:  Luca Cartegni; Jinhua Wang; Zhengwei Zhu; Michael Q Zhang; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

View more
  8 in total

1.  A genotype-first analysis in a cohort of Mullerian anomaly.

Authors:  Weijie Tian; Na Chen; Yang Ye; Congcong Ma; Chenglu Qin; Yuchen Niu; L Xiaoxin; Lina Zhao; Hengqiang Zhao; Ze Liang; Shuang Song; Yuan Wang; Zefu Chen; Jiachen Lin; Zihui Yan; Jiali Duan; Sen Zhao; Terry Jianguo Zhang; Guixing Qiu; Zhihong Wu; Nan Wu; Lan Zhu
Journal:  J Hum Genet       Date:  2022-01-13       Impact factor: 3.172

2.  Expanding congenital abnormalities of the kidney and urinary tract (CAKUT) genetics: basonuclin 2 (BNC2) and lower urinary tract obstruction.

Authors:  Raul Fernandez-Prado; Mehmet Kanbay; Alberto Ortiz; Maria Vanessa Perez-Gomez
Journal:  Ann Transl Med       Date:  2019-09

3.  Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON.

Authors:  Alexander J M Dingemans; Kim M G Truijen; Jung-Hyun Kim; Zahide Alaçam; Laurence Faivre; Kathleen M Collins; Erica H Gerkes; Mieke van Haelst; Ingrid M B H van de Laar; Kristin Lindstrom; Mathilde Nizon; James Pauling; Edyta Heropolitańska-Pliszka; Astrid S Plomp; Caroline Racine; Rani Sachdev; Margje Sinnema; Jon Skranes; Hermine E Veenstra-Knol; Eline A Verberne; Anneke T Vulto-van Silfhout; Marlon E F Wilsterman; Eun-Young Erin Ahn; Bert B A de Vries; Lisenka E L M Vissers
Journal:  Eur J Hum Genet       Date:  2021-09-15       Impact factor: 5.351

4.  Knockdown of Son, a mouse homologue of the ZTTK syndrome gene, causes neuronal migration defects and dendritic spine abnormalities.

Authors:  Masashi Ueda; Tohru Matsuki; Masahide Fukada; Shima Eda; Akie Toya; Akio Iio; Hidenori Tabata; Atsuo Nakayama
Journal:  Mol Brain       Date:  2020-05-24       Impact factor: 4.041

5.  Phenotypic expansion in Zhu-Tokita-Takenouchi-Kim syndrome caused by de novo variants in the SON gene.

Authors:  Ryszard Slezak; Robert Smigiel; Malgorzata Rydzanicz; Agnieszka Pollak; Joanna Kosinska; Piotr Stawinski; Maria Malgorzata Sasiadek; Rafal Ploski
Journal:  Mol Genet Genomic Med       Date:  2020-07-24       Impact factor: 2.183

6.  son is necessary for proper vertebrate blood development.

Authors:  Rebecca L Belmonte; Isabella L Engbretson; Jung-Hyun Kim; Illiana Cajias; Eun-Young Erin Ahn; David L Stachura
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

7.  ZTTK syndrome: Clinical and molecular findings of 15 cases and a review of the literature.

Authors:  Sulagna Tina Kushary; Anya Revah-Politi; Subit Barua; Mythily Ganapathi; Andrea Accogli; Vimla Aggarwal; Nicola Brunetti-Pierri; Gerarda Cappuccio; Valeria Capra; Christina R Fagerberg; Gabriella Gazdagh; Edwin Guzman; Medard Hadonou; Victoria Harrison; Kathrine Havelund; Daniela Iancu; Alison Kraus; Natalie C Lippa; Mahesh Mansukhani; Danielle McBrian; Meriel McEntagart; Marta Pacio-Míguez; María Palomares-Bralo; Carrie Pottinger; Claudia A L Ruivenkamp; Oliviero Sacco; Gijs W E Santen; Fernando Santos-Simarro; Marcello Scala; John Short; Kristina P Sørensen; Christopher G Woods; Kwame Anyane Yeboa
Journal:  Am J Med Genet A       Date:  2021-07-31       Impact factor: 2.578

8.  A novel frameshift variant in SON causes Zhu-Tokita-Takenouchi-Kim Syndrome.

Authors:  Ya Tan; Ling Duan; Kai Yang; Qian Liu; Jing Wang; Zhe Dong; Zhi Li; Yiwen He; Yousheng Yan; Li Lin
Journal:  J Clin Lab Anal       Date:  2020-04-14       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.